ARCHIVES

NIH May Claim BRCA1 Rights, While Myriad Files For Patent

This article is from The Cancer Letter archive.

Vol. 20 No. 38 | October 7, 1994

Download PDF Visit The Full Archive

Related Articles

Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression

November 30, 2012

TGen and George Mason Form Precision Medicine Alliance

May 16, 2014

Cancer Groups Endorse Pazdur For FDA Commissioner.

January 19, 2001

White House Announces FDA Initiatives To accelerate Cancer Drug Approval

April 4, 1996

DeVita Considers Alternatives to Recommendation Of NCAB On Organ Systems Coordinating Center

June 1, 1984

Obituary: NCI’s Elaine Ron, Expert in Radiation Heath Effects

December 3, 2010